VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $218,190,424 | -4.8% | 8,108,154 | +6.5% | 1.28% | -0.9% |
Q2 2023 | $229,273,408 | -19.1% | 7,614,527 | -13.1% | 1.29% | -32.7% |
Q1 2023 | $283,338,543 | +21.8% | 8,758,533 | +7.9% | 1.92% | -1.4% |
Q4 2022 | $232,691,973 | +16.1% | 8,119,050 | -2.3% | 1.95% | -8.7% |
Q3 2022 | $200,472,000 | -9.9% | 8,311,455 | +2.3% | 2.13% | +4.3% |
Q2 2022 | $222,439,000 | -36.7% | 8,124,150 | -11.4% | 2.05% | -1.8% |
Q1 2022 | $351,628,000 | -1.7% | 9,168,910 | -17.9% | 2.08% | +10.7% |
Q4 2021 | $357,823,000 | -11.6% | 11,171,500 | -18.7% | 1.88% | -31.9% |
Q3 2021 | $404,714,000 | -20.2% | 13,733,090 | -8.0% | 2.76% | -13.5% |
Q2 2021 | $507,305,000 | +10.6% | 14,929,526 | +5.8% | 3.20% | +1.9% |
Q1 2021 | $458,703,000 | -24.5% | 14,113,952 | -16.4% | 3.13% | -47.2% |
Q4 2020 | $607,824,000 | +14.0% | 16,874,633 | +24.0% | 5.94% | -7.8% |
Q3 2020 | $533,049,000 | +131.7% | 13,612,077 | +117.1% | 6.45% | +98.9% |
Q2 2020 | $230,018,000 | +0.1% | 6,270,947 | -37.1% | 3.24% | -66.3% |
Q1 2020 | $229,772,000 | -65.0% | 9,972,750 | -55.5% | 9.62% | -4.6% |
Q4 2019 | $655,600,000 | +2.3% | 22,390,711 | -6.7% | 10.08% | +0.6% |
Q3 2019 | $640,842,000 | +359.4% | 23,992,603 | +339.6% | 10.02% | +308.7% |
Q2 2019 | $139,489,000 | -55.4% | 5,457,298 | -60.9% | 2.45% | -51.3% |
Q1 2019 | $312,619,000 | +8.4% | 13,943,745 | +2.0% | 5.03% | -20.0% |
Q4 2018 | $288,427,000 | -47.6% | 13,675,986 | -54.0% | 6.29% | -26.3% |
Q3 2018 | $550,693,000 | -1.2% | 29,735,058 | +19.0% | 8.53% | +2.4% |
Q2 2018 | $557,648,000 | +32.5% | 24,995,435 | +30.5% | 8.33% | +33.6% |
Q1 2018 | $420,922,000 | -2.1% | 19,150,236 | +3.5% | 6.24% | -16.1% |
Q4 2017 | $430,128,000 | +27.3% | 18,508,104 | +25.8% | 7.43% | -1.9% |
Q3 2017 | $337,783,000 | +151.0% | 14,711,791 | +141.3% | 7.58% | +96.1% |
Q2 2017 | $134,596,000 | -86.3% | 6,095,812 | -85.8% | 3.86% | -82.1% |
Q1 2017 | $980,584,000 | +56.1% | 42,989,201 | +43.2% | 21.61% | -24.9% |
Q4 2016 | $628,212,000 | -29.3% | 30,029,278 | -10.7% | 28.78% | -11.4% |
Q3 2016 | $888,919,000 | +357.8% | 33,632,946 | +379.8% | 32.46% | +147.2% |
Q2 2016 | $194,174,000 | – | 7,009,879 | – | 13.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |